Earnings · China A-shares
Dizal Pharmaceutical Co., Ltd. Class A (688192) earnings
Dizal Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit +727.43% year on year, +672.74% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved +14.94% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- +727.43%
- Excl. one-offs YoY
- +672.74%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +9.50% | — |
| 3 days | +14.94% | — |
| 7 days | +18.86% | — |
| 14 days | +1.67% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +1.37%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | ¥3.64B | +727.43% | +672.74% | +713.50% | 7.83 | 115.44% | +14.94% | — | — |
| 2026 interim report | 2026-08-21 | -¥210.37M | +44.25% | +44.84% | +47.24% | -0.45 | -17.21% | -3.14% | -3.54% | +2.16% |
| 2026 Q1 report | 2026-04-30 | -¥95.56M | +50.36% | +50.41% | +58.18% | -0.21 | -7.53% | +2.45% | -31.69% | -33.75% |
| 2025 annual report | 2026-03-31 | -¥764.05M | +9.68% | +6.38% | +122.60% | -1.71 | -74.02% | +5.34% | -4.10% | -12.52% |
| 2025 Q3 report | 2025-10-31 | -¥579.95M | -3.85% | -5.19% | +73.23% | -1.32 | -63.34% | +5.92% | +4.06% | +8.75% |
| 2025 interim report | 2025-08-23 | -¥377.36M | -9.46% | -10.10% | +74.40% | -0.87 | -61.52% | -9.06% | -19.93% | -24.80% |
| 2025 Q1 report | 2025-04-30 | -¥192.51M | +14.15% | +13.84% | +96.32% | -0.46 | -181.43% | -6.88% | +11.37% | +8.19% |
| 2024 annual report | 2025-04-30 | -¥845.96M | +23.63% | +22.56% | +294.24% | -2.04 | -161.12% | -6.88% | +11.37% | +8.19% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
Stock valuations: 688192 · Stock news: 688192
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.